AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its ...

The FDA is alerting veterinarians about reports of health problems in dogs, including hundreds of deaths, tied to a drug for ...

Channel 2 Action News has learned that the FDA is now alerting veterinarians about reports of health problems in dogs – ...

In 2024, significant biosimilar approvals were granted by the American and European regulatory agencies, including the first ...

Anavex Life Sciences receives EMA filing acceptance for blarcamesine to review marketing authorization application to treat Alzheimer’s disease: New York Thursday, December 26, ...

Novo Nordisk resumed its rally on Tuesday, rising to the top of the Stoxx 600 during early deals and adding 5.7% by 11:05 a.m ...

AstraZeneca (AZN) and Daiichi Sankyo (DSNKY) withdraw EU marketing application for lung cancer therapy Dato-DXd. Read more ...

Cytokinetics (CYTK) announced that the European Medicines Agency, EMA, has validated the Marketing Authorization Application, MAA, for ...

Life Sciences announced that the European Medicines Agency, EMA, has accepted for review the Marketing Authorization Application, ...

Anavex (AVXL) stock rallied 30% Monday after the company announced EU regulators had accepted the market application for its ...

AstraZeneca said it and Daiichi Sankyo decided to voluntarily withdraw the marketing authorization application in the European Union for advanced lung-cancer treatment Dato-DXd. This decision followed ...